CMF-05131 | NEB | down-regulates | PAX5 | represses | R-350 | 6 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-14644 | C1orf177 | down-regulates | PAX5 | represses | R-350 | 6 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-16762 | CPNE8 | down-regulates | PAX5 | represses | R-350 | 6 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-24072 | TP53 | up-regulates | PAX5 | represses | R-350 | 6 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-26605 | NAALADL1 | down-regulates | PAX5 | represses | R-350 | 6 | 3 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-27480 | SDK1 | down-regulates | PAX5 | represses | R-350 | 6 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-27659 | ANKRD36 | down-regulates | PAX5 | represses | R-350 | 6 | 3 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-28029 | AMPD1 | down-regulates | PAX5 | represses | R-350 | 6 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-33894 | SKAP2 | down-regulates | hsa-mir-641 | represses | R-350 | 8 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-34859 | NEB | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-34864 | NEB | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 7 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35051 | FGFR3 | down-regulates | hsa-mir-454-3p | represses | R-350 | 31 | 29 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35082 | FGFR3 | down-regulates | hsa-mir-20b | represses | R-350 | 44 | 26 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35192 | SCNN1G | up-regulates | hsa-mir-106b | represses | R-350 | 21 | 13 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35959 | AHNAK2 | up-regulates | hsa-mir-361 | represses | R-350 | 14 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35973 | AHNAK2 | up-regulates | hsa-mir-106b | represses | R-350 | 21 | 16 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-35995 | AHNAK2 | up-regulates | hsa-mir-93 | represses | R-350 | 44 | 26 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36013 | AHNAK2 | up-regulates | hsa-mir-10b | represses | R-350 | 14 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36023 | AHNAK2 | up-regulates | hsa-mir-20b | represses | R-350 | 44 | 26 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36152 | TNK2 | up-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 40 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36679 | ALB | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36689 | ATP8A2 | up-regulates | hsa-mir-454-3p | represses | R-350 | 31 | 27 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36728 | ATP8A2 | up-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 40 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36758 | ATP8A2 | up-regulates | hsa-mir-93 | represses | R-350 | 44 | 32 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-36792 | ATP8A2 | up-regulates | hsa-mir-20b | represses | R-350 | 44 | 31 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37173 | CYP4F22 | down-regulates | hsa-mir-7 | represses | R-350 | 18 | 17 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37184 | CYP4F22 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 18 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37232 | OR2T6 | down-regulates | hsa-mir-30b | represses | R-350 | 9 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37376 | SLCO6A1 | up-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 3 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37695 | ADAMTS8 | up-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 40 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37717 | CDKN2C | down-regulates | hsa-mir-641 | represses | R-350 | 8 | 2 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-37872 | PRKCD | up-regulates | hsa-mir-641 | represses | R-350 | 8 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38086 | OR51F1 | up-regulates | hsa-mir-106b | represses | R-350 | 21 | 17 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38106 | OR51F1 | up-regulates | hsa-mir-93 | represses | R-350 | 44 | 35 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38321 | ZNF845 | up-regulates | hsa-mir-454-3p | represses | R-350 | 31 | 27 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38347 | ZNF845 | up-regulates | hsa-mir-641 | represses | R-350 | 8 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38407 | KCNB2 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38412 | KCNB2 | down-regulates | hsa-mir-361 | represses | R-350 | 14 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38416 | KCNB2 | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38425 | KCNB2 | down-regulates | hsa-mir-106b | represses | R-350 | 21 | 15 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38448 | KCNB2 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 36 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38477 | KCNB2 | down-regulates | hsa-mir-93 | represses | R-350 | 44 | 27 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38549 | TBX5 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38550 | TBX5 | down-regulates | hsa-mir-361 | represses | R-350 | 14 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38551 | TBX5 | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38568 | CPNE8 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 28 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38590 | CPNE8 | down-regulates | hsa-mir-93 | represses | R-350 | 44 | 20 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38607 | ADAMTS2 | down-regulates | hsa-mir-10b | represses | R-350 | 14 | 2 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38827 | CDH18 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38975 | SGIP1 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38976 | SGIP1 | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-38985 | SGIP1 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 26 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39010 | SGIP1 | down-regulates | hsa-mir-93 | represses | R-350 | 44 | 23 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39033 | SGIP1 | down-regulates | hsa-mir-20b | represses | R-350 | 44 | 23 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39142 | DNMBP | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 35 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39224 | ZNF569 | up-regulates | hsa-mir-7 | represses | R-350 | 18 | 3 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39318 | SLFN13 | down-regulates | hsa-mir-10b | represses | R-350 | 14 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39334 | INPP5J | up-regulates | hsa-mir-641 | represses | R-350 | 8 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39557 | NF1 | down-regulates | hsa-mir-106b | represses | R-350 | 21 | 20 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39625 | NF1 | down-regulates | hsa-mir-93 | represses | R-350 | 44 | 31 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39661 | NF1 | down-regulates | hsa-mir-10b | represses | R-350 | 14 | 2 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39715 | NF1 | down-regulates | hsa-mir-20b | represses | R-350 | 44 | 31 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39744 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 12 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39770 | RPSAP58 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 40 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39795 | RPSAP58 | down-regulates | hsa-mir-641 | represses | R-350 | 8 | 7 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39824 | UGT2B4 | down-regulates | hsa-mir-149 | represses | R-350 | 51 | 35 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39857 | OR6C75 | down-regulates | hsa-mir-30b | represses | R-350 | 9 | 3 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39901 | TDRD9 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 16 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39916 | TDRD9 | down-regulates | hsa-mir-361 | represses | R-350 | 14 | 9 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39929 | TDRD9 | down-regulates | hsa-mir-106b | represses | R-350 | 21 | 21 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-39962 | TDRD9 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 42 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-40136 | STAB2 | up-regulates | hsa-mir-106b | represses | R-350 | 21 | 8 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-40140 | STAB2 | up-regulates | hsa-mir-10b | represses | R-350 | 14 | 1 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-40168 | KRTAP4-7 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 5 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-40204 | KRTAP4-7 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 17 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-40310 | MUC17 | down-regulates | hsa-mir-30b | represses | R-350 | 9 | 9 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41270 | TP53 | up-regulates | hsa-mir-301 | represses | R-350 | 37 | 28 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41336 | TP53 | up-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 52 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41379 | TP53 | up-regulates | hsa-mir-93 | represses | R-350 | 44 | 44 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41540 | TP53 | up-regulates | hsa-mir-20b | represses | R-350 | 44 | 44 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41774 | IQSEC3 | up-regulates | hsa-mir-454-3p | represses | R-350 | 31 | 25 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41812 | IQSEC3 | up-regulates | hsa-mir-30b | represses | R-350 | 9 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41865 | IQSEC3 | up-regulates | hsa-mir-641 | represses | R-350 | 8 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-41904 | IQSEC3 | up-regulates | hsa-mir-20b | represses | R-350 | 44 | 34 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42077 | A1CF | up-regulates | hsa-mir-30d | represses | R-350 | 29 | 2 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42185 | NAALADL1 | down-regulates | hsa-mir-301 | represses | R-350 | 37 | 10 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42356 | SDK1 | down-regulates | hsa-mir-7 | represses | R-350 | 18 | 14 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42394 | KRTAP20-2 | down-regulates | hsa-mir-7 | represses | R-350 | 18 | 15 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42420 | ANKRD36 | down-regulates | hsa-mir-30d | represses | R-350 | 29 | 11 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42440 | ANKRD36 | down-regulates | hsa-mir-641 | represses | R-350 | 8 | 6 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-42467 | FSTL5 | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 16 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-43251 | PROKR2 | up-regulates | hsa-mir-30b | represses | R-350 | 9 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-43288 | POLRMT | down-regulates | hsa-mir-7 | represses | R-350 | 18 | 7 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-43296 | POLRMT | down-regulates | hsa-mir-17-3p | represses | R-350 | 52 | 9 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |
CMF-43339 | LRFN2 | up-regulates | hsa-mir-30b | represses | R-350 | 9 | 4 | Drugs (20) Regulator Drugs (0)Regulon Drugs (20)DASATINIB, VOBARILIZUMAB, BOSUTINIB, BAFETINIB, TOCILIZUMAB, ILORASERTIB, JNJ-26483327, SARILUMAB, XL-228, SATRALIZUMAB, IC14, TOLIMIDONE, ERITORAN TETRASODIUM, TG100-801, VB-201, ERITORAN, MILATUZUMAB, LEVILIMAB, AMG-557, ENMD-981693 |